• Consensus Rating: N/A
  • Consensus Price Target: C$0.00
  • Forecasted Upside: NaN
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
C$0.00
+0 (0.00%)

This chart shows the closing price for CRH by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New CRH Medical Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CRH and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CRH

Analyst Price Target is C$0.00
This price target is based on 0 analysts offering 12 month price targets for CRH Medical in the last 3 months. The average price target is C$0.00, with a high forecast of C$0.00 and a low forecast of C$10,000,000.00. The average price target represents a NaN upside from the last price of C$0.00.

This chart shows the closing price for CRH for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 investment analysts is to n/a stock in CRH Medical. This rating has held steady since January 2022, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
2/24/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
5/25/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
8/23/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
11/21/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/19/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/20/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/19/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/18/2022

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
2/9/2021National Bank FinancialDowngradeOutperform ➝ TenderC$4.25 ➝ C$5.10
2/9/2021Royal Bank of CanadaDowngradeOutperform ➝ Sector PerformC$4.00 ➝ C$5.00
12/24/2020Royal Bank of CanadaLower TargetC$4.50 ➝ C$4.00
12/23/2020Bloom BurtonDowngradeBuy ➝ Hold
8/12/2020Bloom BurtonReiterated RatingBuy
5/14/2020Beacon SecuritiesDowngradeBuy ➝ Hold
5/4/2020National Bank FinancialLower TargetOutperformC$4.25 ➝ C$4.00
3/13/2020Royal Bank of CanadaLower TargetOutperformC$6.50 ➝ C$4.75
3/5/2020National Bank FinancialLower TargetC$6.25 ➝ C$5.50
2/5/2020Royal Bank of CanadaBoost TargetOutperformC$5.50 ➝ C$6.50
2/3/2020National Bank FinancialBoost TargetOutperformC$5.75 ➝ C$6.25
8/1/2019Bloom BurtonUpgradeAccumulate ➝ Buy
3/20/2019Clarus SecuritiesReiterated RatingBuy
3/15/2019Acumen CapitalLower TargetC$6.25 ➝ C$6.00
1/9/2019TD SecuritiesLower TargetBuyC$6.50 ➝ C$5.50
9/5/2018TD SecuritiesBoost TargetBuyC$5.50 ➝ C$6.50
9/5/2018Royal Bank of CanadaBoost TargetOutperformC$5.00 ➝ C$5.50
8/21/2018National Bank FinancialBoost TargetOutperformC$5.00 ➝ C$5.75
8/3/2018TD SecuritiesBoost TargetBuyC$5.00 ➝ C$5.50
8/3/2018Royal Bank of CanadaBoost TargetOutperformC$4.75 ➝ C$5.00
7/27/2018TD SecuritiesUpgradeHold ➝ BuyC$4.00 ➝ C$5.00
5/2/2018TD SecuritiesBoost TargetHoldC$3.50 ➝ C$4.00
5/2/2018Royal Bank of CanadaBoost TargetOutperformC$4.50 ➝ C$4.75
5/1/2018National Bank FinancialBoost TargetOutperformC$4.50 ➝ C$5.00
3/7/2018TD SecuritiesBoost TargetHoldC$2.50 ➝ C$3.50
3/6/2018National Bank FinancialBoost TargetOutperformC$4.25 ➝ C$4.50
11/6/2017National Bank FinancialLower TargetOutperformC$5.25 ➝ C$4.25
11/6/2017TD SecuritiesLower TargetHoldC$3.25 ➝ C$2.50
11/3/2017ScotiabankLower TargetOutperformC$6.00 ➝ C$4.25
11/2/2017Royal Bank of CanadaLower TargetOutperformC$5.00 ➝ C$4.50
9/25/2017ScotiabankLower TargetOutperformC$6.75 ➝ C$6.00
9/25/2017TD SecuritiesLower TargetHoldC$5.50 ➝ C$4.00
(Data available from 8/18/2017 forward)

News Sentiment Rating

0.00 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
1/20/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/19/2022
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
3/21/2022
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/20/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/20/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/19/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/19/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/18/2022

Current Sentiment

  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
CRH Medical logo
CRH Medical Corporation provides anesthesia services for patients undergoing endoscopic procedures in ambulatory surgical centers in the United States and Canada. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology to treat various grades of hemorrhoid. The company distributes CRH O'Regan system, treatment protocols, and operational and marketing expertise as a turnkey package directly to gastroenterology practices. It also offers a hemorrhoid banding ancillary program, cybersecurity, and a consumer-centric digital application. The company was formerly known as Medsurge Medical Products Corp. and changed its name to CRH Medical Corporation in April 2006. CRH Medical Corporation was founded in 2000 and is headquartered in Vancouver, Canada. As of April 22, 2021, CRH Medical Corporation operates as a subsidiary of WELL Health Technologies Corp.
Read More

Today's Range

Now: N/A

50 Day Range

MA: C$4.99
Low: C$4.99
High: C$4.99

52 Week Range

Now: N/A

Volume

36,923 shs

Average Volume

190,654 shs

Market Capitalization

C$357.38 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of CRH Medical?

The following Wall Street sell-side analysts have issued stock ratings on CRH Medical in the last twelve months:
View the latest analyst ratings for CRH.

What is the current price target for CRH Medical?

0 Wall Street analysts have set twelve-month price targets for CRH Medical in the last year. has the lowest price target set, forecasting a price of C$10,000,000.00 for CRH Medical in the next year.
View the latest price targets for CRH.

What is the current consensus analyst rating for CRH Medical?

CRH Medical currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for CRH.

What other companies compete with CRH Medical?

How do I contact CRH Medical's investor relations team?

CRH Medical's physical mailing address is 57B - 999 Canada Place World Trade Center, VANCOUVER, BC V6C 3E1, Canada. The company's listed phone number is +1-604-6331440. The official website for CRH Medical is investors.crhsystem.com. Learn More about contacing CRH Medical investor relations.